181 related articles for article (PubMed ID: 14693596)
1. Antagonism of cisatracurium and rocuronium block at a tactile train-of-four count of 2: should quantitative assessment of neuromuscular function be mandatory?
Kopman AF; Zank LM; Ng J; Neuman GG
Anesth Analg; 2004 Jan; 98(1):102-106. PubMed ID: 14693596
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Kopman AF; Kopman DJ; Ng J; Zank LM
J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
[TBL] [Abstract][Full Text] [Related]
3. [Influence of neostigmine on the course of neuromuscular blockade with rocuronium or cisatracurium: a randomized, double-blind trial].
Barrio J; San Miguel G; García V; Pelegrín F
Rev Esp Anestesiol Reanim; 2007; 54(7):399-404. PubMed ID: 17953333
[TBL] [Abstract][Full Text] [Related]
4. Cisatracurium- and rocuronium-associated residual neuromuscular dysfunction under intraoperative neuromuscular monitoring and postoperative neostigmine reversal: a single-blind randomized trial.
Feltracco P; Tonetti T; Barbieri S; Frigo AC; Ori C
J Clin Anesth; 2016 Dec; 35():198-204. PubMed ID: 27871520
[TBL] [Abstract][Full Text] [Related]
5. Residual postoperative paralysis. Pancuronium versus mivacurium, does it matter?
Kopman AF; Ng J; Zank LM; Neuman GG; Yee PS
Anesthesiology; 1996 Dec; 85(6):1253-9. PubMed ID: 8968171
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of residual neuromuscular block and postoperative respiratory complications in patients reversed with neostigmine versus sugammadex.
Martinez-Ubieto J; Ortega-Lucea S; Pascual-Bellosta A; Arazo-Iglesias I; Gil-Bona J; Jimenez-Bernardó T; Muñoz-Rodriguez L
Minerva Anestesiol; 2016 Jul; 82(7):735-42. PubMed ID: 26472231
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion.
Mellinghoff H; Radbruch L; Diefenbach C; Buzello W
Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288
[TBL] [Abstract][Full Text] [Related]
8. Optimum dose of neostigmine to reverse shallow neuromuscular blockade with rocuronium and cisatracurium.
Choi ES; Oh AY; Seo KS; Hwang JW; Ryu JH; Koo BW; Kim BG
Anaesthesia; 2016 Apr; 71(4):443-9. PubMed ID: 26874258
[TBL] [Abstract][Full Text] [Related]
9. Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.
Kotake Y; Ochiai R; Suzuki T; Ogawa S; Takagi S; Ozaki M; Nakatsuka I; Takeda J
Anesth Analg; 2013 Aug; 117(2):345-51. PubMed ID: 23757472
[TBL] [Abstract][Full Text] [Related]
10. Postoperative residual curarization with cisatracurium and rocuronium infusions.
Cammu G; de Baerdemaeker L; den Blauwen N; de Mey JC; Struys M; Mortier E
Eur J Anaesthesiol; 2002 Feb; 19(2):129-34. PubMed ID: 11999596
[TBL] [Abstract][Full Text] [Related]
11. Reversal of rocuronium-induced neuromuscular block with sugammadex is faster than reversal of cisatracurium-induced block with neostigmine.
Flockton EA; Mastronardi P; Hunter JM; Gomar C; Mirakhur RK; Aguilera L; Giunta FG; Meistelman C; Prins ME
Br J Anaesth; 2008 May; 100(5):622-30. PubMed ID: 18385265
[TBL] [Abstract][Full Text] [Related]
12. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
[TBL] [Abstract][Full Text] [Related]
13. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
[TBL] [Abstract][Full Text] [Related]
14. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action.
Debaene B; Plaud B; Dilly MP; Donati F
Anesthesiology; 2003 May; 98(5):1042-8. PubMed ID: 12717123
[TBL] [Abstract][Full Text] [Related]
15. Tactile assessment for the reversibility of rocuronium-induced neuromuscular blockade during propofol or sevoflurane anesthesia.
Kim KS; Cheong MA; Lee HJ; Lee JM
Anesth Analg; 2004 Oct; 99(4):1080-1085. PubMed ID: 15385354
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia.
Amin AM; Mohammad MY; Ibrahim MF
Middle East J Anaesthesiol; 2009 Feb; 20(1):39-51. PubMed ID: 19266825
[TBL] [Abstract][Full Text] [Related]
17. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
18. The clinical neuromuscular pharmacology of cisatracurium versus vecuronium during outpatient anesthesia.
Stevens JB; Walker SC; Fontenot JP
Anesth Analg; 1997 Dec; 85(6):1278-83. PubMed ID: 9390594
[TBL] [Abstract][Full Text] [Related]
19. Dose-response relationships for edrophonium and neostigmine antagonism of rocuronium bromide (ORG 9426)-induced neuromuscular blockade.
Naguib M; Abdulatif M; al-Ghamdi A
Anesthesiology; 1993 Oct; 79(4):739-45. PubMed ID: 8214753
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a Protocol for the Management of Maintenance and Reversal of Rocuronium Block Using Neostigmine or Sugammadex.
Thilen SR; Liang T; Kruse TN; Cain KC; Treggiari MM; Bhananker SM
Anesth Analg; 2023 Jun; 136(6):1143-1153. PubMed ID: 37205804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]